Clinical Trials Logo

Filter by:
NCT ID: NCT05233657 Recruiting - Schizophrenia Clinical Trials

A Safety,Tolerability and Pharmacokinetics Clinical Trial of JX11502MA Capsule

Start date: January 4, 2020
Phase: Phase 1
Study type: Interventional

The purpose of this study is to investigate the safety, tolerability and pharmacokinetic characteristics of JX11502MA capsule on healthy human, and to explore the relationship between the dose, pharmacokinetic parameters and safety of JX11502MA capsule,so as to provide basis for the follow-up clinical trials (multi-dose tolerability, pharmacokinetics and phase II trial, etc.).

NCT ID: NCT05233332 Recruiting - CRC Clinical Trials

Study of HL-085 and Vemurafinib in Metastatic Colorectal Cancer (mCRC)

mCRC
Start date: February 24, 2022
Phase: Phase 2
Study type: Interventional

The study consists of the two parts, phase IIa and phase IIb.

NCT ID: NCT05232903 Recruiting - Clinical trials for Spontaneous Intracerebral Hemorrhage

Stromal Vascular Fraction (SVF) Therapy in Patients With Acute Spontaneous Intracerebral Hemorrhage (SICH).

Start date: March 1, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this pilot study is to evaluate the safety of stromal vascular fraction (SVF) therapy in patients with spontaneous intracerebral hemorrhage (SICH).

NCT ID: NCT05232552 Recruiting - Clinical trials for Nasopharyngeal Carcinoma

Study of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal Carcinoma

Start date: January 1, 2021
Phase: Phase 2
Study type: Interventional

anlotinib was added to TP inductive chemotherapy and definitive chemoradiation in nasopharyngeal carcinoma patients with N2-3 disease with necrosis or/and ECM

NCT ID: NCT05232357 Recruiting - Clinical trials for Gastrointestinal Neoplasms

Endoscopic Vital Nerve Staining in Gastrointestinal Diseases

Start date: March 1, 2022
Phase: Early Phase 1
Study type: Interventional

In this study, methylene blue (MB) was used as vital nerve staining agent. During gastroenteroscopy, mucosal nerve staining was achieved by endoscopic submucosal injection of MB solution. To observe the staining of nerve fibers, neurons and glial cells in mucosa and submucosa, as well as the morphological changes, density differences and function of mucosal nerve tissues in different gastrointestinal lesions, in order to explore the role of endoscopic vital nerve staining in the diagnosis of gastrointestinal lesions.

NCT ID: NCT05232240 Recruiting - Clinical trials for Ischemic Cerebrovascular Disease

Blood Pressure Variability in Non-hypertensive Patients With Ischemic Cerebrovascular Disease

BPV-NhICVD
Start date: February 14, 2022
Phase:
Study type: Observational

This study is a single-center prospective cohort of patients with ischemic cerebrovascular disease (ICVD) who have not met the diagnostic criteria for hypertension. Ambulatory 24-hour blood pressure monitoring (ABPM) will be performed at baseline and one year after the enrollment. The primary purpose of the study is to delineate the relationship of blood pressure variability (BPV) with the risk of composite vascular events in non-hypertensive patients with ICVD. The factors related to BPV, as well as the potential modulators of the associations between BPV and vascular risk, will be further explored among these patients.

NCT ID: NCT05232149 Recruiting - Clinical trials for Primary Immune Thrombocytopenia

A Study to Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Immune Thrombocytopenia

Start date: February 21, 2022
Phase: Phase 2
Study type: Interventional

The study is designed to be a randomized, open, multi-center, phase IIa/IIb seamless adaptive trial. Phase IIa: The study consists of a screening period, a core treatment period, an open label extension period, and a safety follow-up period Phase IIb: At present, a preliminary exploratory study (i.e., phase IIa study) will be conducted first. The design of the phase IIb study (including the selection of populations) will be clarified after a relatively clear understanding of the therapeutic effect, value, risks and benefits of the BTK inhibitor for ITP is obtained.

NCT ID: NCT05232136 Recruiting - Clinical trials for Non-muscle-invasive Bladder Cancer

OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder Cancer

Start date: July 11, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

This phase Ⅰb/Ⅱ study evaluates the safety and efficacy of OH2 for adjuvant therapy in non-muscle-invasive bladder cancer after first-line prophylactic intravesical instillation therapy. OH2 is an oncolytic virus developed upon genetic modifications of the herpes simplex virus type 2 strain HG52, allowing the virus to selectively replicate in tumors. Meanwhile, the delivery of the gene encoding human granulocyte macrophage colony-stimulating factor (GM-CSF) may induce a more potent antitumor immune response.

NCT ID: NCT05231902 Recruiting - ADHD Clinical Trials

Prevalence of Attention Deficit/Hyperactivity Disorder and Parenting Stress in School-age Children in Chongqing, China

PADHDPS
Start date: June 1, 2021
Phase:
Study type: Observational

Attention deficit hyperactivity disorder (ADHD) is a common chronic neurodevelopmental disorder. Around 7.2% of children around the world are suffering from ADHD, while a chinese meta-analysis shows that the prevalence is 6.28%. There is no study of ADHD prevalence have used population-based samples, and depending on Vanderbilt ADHD Diagnostic Parent Rating Scale (VADPRS), in Chongqing, China. The purpose of the study is to investigate the prevalence of ADHD in school-age children and the parenting stress of parents of ADHD children in Chongqing. According to the proportion of primary school students in the four regions of Chongqing, using stratified proportional random sampling, 6480 primary school students are proposed to be selected as the research object, and questionnaires will complete by their caregivers and class teachers. VADPRS is used to evaluate the prevalence. Caregiver strain questionnaire (CGSQ) was used to assess parenting stress. Because of the nature of ADHD and the seriousness of its consequences, the periodic estimation of the prevalence of ADHD has been a critical research aim. This study can not only evaluate the prevalence of ADHD and parenting stress of parents of children with ADHD, but also use campus screening to promote parents and teachers' understanding of ADHD and improve the treatment rate.

NCT ID: NCT05231863 Recruiting - Breast Cancer Clinical Trials

Tyrosine Kinase Inhibitors (TKIs) in Trastuzumab Emtansine (T-DM1) Resistant HER2-positive Metastatic Breast Cancer: A Real-world Study

Start date: August 1, 2019
Phase:
Study type: Observational

This is a real world study to evaluate the efficacy and safety of tyrosine kinase inhibitors after T-DM1 progression.